Editas Medicine (EDIT) Cash from Investing Activities (QoQ) (2015 - 2025)
Powered by 
Analysis
Editas Medicine (EDIT) Cash from Investing Activities (QoQ) (2015 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Editas Medicine | 287.84 Mn | 141.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -7.21% |
| Jun 30, 2025 | -24.36% |
| Mar 31, 2025 | 82.14% |
| Dec 31, 2024 | -63.14% |
| Sep 30, 2024 | 61.64% |
| Jun 30, 2024 | 1,194.92% |
| Mar 31, 2024 | -107.55% |
| Dec 31, 2023 | 161.12% |
| Sep 30, 2023 | -892.02% |
| Jun 30, 2023 | -44.20% |
| Mar 31, 2023 | 184.52% |
| Dec 31, 2022 | -130.85% |
| Sep 30, 2022 | 2,329.56% |
| Jun 30, 2022 | -107.10% |
| Mar 31, 2022 | 346.81% |
| Dec 31, 2021 | 42.41% |
| Sep 30, 2021 | -927.82% |
| Jun 30, 2021 | 47.69% |
| Mar 31, 2021 | 102.98% |
| Dec 31, 2020 | 28.48% |